KPC Pharmaceuticals,Inc.

SHSE:600422 Stock Report

Market Cap: CN¥10.9b

KPC PharmaceuticalsInc Future Growth

Future criteria checks 3/6

KPC PharmaceuticalsInc is forecast to grow earnings and revenue by 28.1% and 13.8% per annum respectively. EPS is expected to grow by 27.9% per annum. Return on equity is forecast to be 12.1% in 3 years.

Key information

28.1%

Earnings growth rate

27.9%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate13.8%
Future return on equity12.1%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Investors Holding Back On KPC Pharmaceuticals,Inc. (SHSE:600422)

Nov 18
Investors Holding Back On KPC Pharmaceuticals,Inc. (SHSE:600422)

Is KPC Pharmaceuticals,Inc. (SHSE:600422) Trading At A 42% Discount?

Sep 30
Is KPC Pharmaceuticals,Inc. (SHSE:600422) Trading At A 42% Discount?

These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely

Sep 11
These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely

KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20

Jul 25
KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20

Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)

Jun 25
Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)

We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt

Jun 04
We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt

KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues

Mar 28
KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues

Earnings and Revenue Growth Forecasts

SHSE:600422 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202610,3468631687736
12/31/20259,4957212796467
12/31/20248,187542-337266
9/30/20247,550446557609N/A
6/30/20247,487451725780N/A
3/31/20247,646432752811N/A
12/31/20237,703445291356N/A
9/30/20237,700397261333N/A
6/30/20237,825390141222N/A
3/31/20237,828400-5138N/A
12/31/20228,282383152254N/A
9/30/20228,419446177296N/A
6/30/20228,388392-23143N/A
3/31/20228,722427-33177N/A
12/31/20218,25450815252N/A
9/30/20218,321540-13693N/A
6/30/20218,386564-22190N/A
3/31/20218,045560-79118N/A
1/1/20217,717457251410N/A
9/30/20207,779445128361N/A
6/30/20207,788444104393N/A
3/31/20207,910443292564N/A
12/31/20198,12045482430N/A
9/30/20197,817429145452N/A
6/30/20197,473390131376N/A
3/31/20197,237356146402N/A
12/31/20187,102336135352N/A
9/30/20186,797316362568N/A
6/30/20186,507295N/A396N/A
3/31/20186,280318N/A197N/A
12/31/20175,852330N/A283N/A
9/30/20175,637357N/A-5N/A
6/30/20175,330374N/A165N/A
3/31/20175,170416N/A179N/A
12/31/20165,101407N/A311N/A
9/30/20165,161440N/A326N/A
6/30/20165,227448N/A378N/A
3/31/20165,049433N/A491N/A
12/31/20154,916421N/A477N/A
9/30/20154,588404N/A485N/A
6/30/20154,456367N/A391N/A
3/31/20154,361308N/A447N/A
12/31/20144,316289N/A404N/A
9/30/20144,038264N/A338N/A
6/30/20143,860258N/A467N/A
3/31/20143,668243N/A325N/A
12/31/20133,584232N/A242N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600422's forecast earnings growth (28.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600422's earnings (28.1% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 600422's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600422's revenue (13.8% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 600422's revenue (13.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600422's Return on Equity is forecast to be low in 3 years time (12.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y